Osteoarthritic Pain – Epidemiology – Mature Markets

DRG Epidemiology’s coverage of osteoarthritis (OA) pain comprises epidemiological estimates of key patient populations in the mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of OA pain for each country, as well as annualized case counts projected to the national population.

DRG Epidemiology’s OA pain forecast will answer the following questions:

  • Of all people with OA pain, how many in each country have been formally diagnosed?
  • How many people diagnosed with OA pain are drug-treated?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following OA pain patient populations:

  • Diagnosed prevalent cases.
  • Diagnosed prevalent cases by drug-treatment status.